An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)

Clinical trial NCT00130806 · TERMINATED

Trial details

NCT number: NCT00130806
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2005-09-01
Primary completion: 2005-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.